71
G. ASLAN ET AL.
a precise digital rectal examination even in low serum
PSA levels.
5. References
[1] S. H. Landis, T. Murray, S. Bolden and P. A. Wingo, “Can-
cer Statistics,” CA: A Cancer Journal for Clinicians, Vol.
48, No. 1, 1998, pp. 6-29. doi:10.3322/canjclin.48.1.6
[2] S. J. Jacobsen, S. K. Katusic, E. J. Bergstralh, et al., “In-
cidence of Prostate Cancer Diagnosis in the Eras before
and after Prostate-Specific Antigen Testing,” The Journal
of the American Medical Association, Vol. 274, No. 18,
1995, pp. 1445-1449. doi:10.1001/jama.274.18.1445
[3] D. S. Smith, P. A. Humphrey and W. J. Catalona, “The
Early Detection of Prostate Carcinoma with Prostate Spe-
cific Antigen: The Washington University Experience,”
Cancer, Vol. 80, No. 9, 1997, pp. 1852-1856.
doi:10.1002/(SICI)1097-0142(19971101)80:9<1852::AI
D-CNCR25>3.3.CO;2-H
[4] G. F. Carvalhal, D. S. Smith, D. E. Mager, C. Ramos and
W. J. Catalona, “Digital Rectal Examination for detecting
Prostate Cancer at Prostate Specific Antigen Levels of 4
ng/ml or Less,” Journal of Urology, Vol. 161, No. 3,
1999, pp. 835-839. doi:10.1016/S0022-5347(01)61785-3
[5] J. L. Gore, S. F. Shariat, B. J. Miles, D. Kadmon, N. Ji-
ang, T. M. Wheeler and K. M. Slawin, “Optimal Combi-
nations of Systemic Sextant and Laterally Directed Biop-
sies for the Detection of Prostate Cancer,” Journal of
Urology, Vol. 165, No. 5, 2001, pp. 1554-1559.
doi:10.1016/S0022-5347(05)66347-1
[6] K. Mistry and G. Cable, “Meta-Analysis of Prostate-Spe-
cific Antigen and Digital Rectal Examination as Screen-
ing Tests for Prostate Carcinoma,” The Journal of the
American Board of Family Medicine, Vol. 16, 2003, No.
2, pp. 95-101. doi:10.3122/jabfm.16.2.95
[7] R. O. Roberts, E. J. Bergstralh, M. M. Lieber and S. J.
Jacobsen, “Digital Rectal Examination and Prostate-Spe-
cific Antigen Abnormalities at the Time of Prostate Bi-
opsy and Biopsy Outcomes, 1980 to 1997,” Urology, Vol.
56, No. 5, 2000, pp. 817-822.
doi:10.1016/S0090-4295(00)00790-1
[8] T. Yamamoto, K. Ito, M. Ohi, et al., “Diagnostic Signifi-
cance of Digital Rectal Examination and Transrectal Ul-
trasonography in Men with Prostate-Specific Antigen
Levels of 4 ng/ml or Less,” Urology, Vol. 58, No. 6, 2001,
pp. 994-998. doi:10.1016/S0090-4295(01)01409-1
[9] J. E. Fowler, S. A. Bigler, P. B. Farabaugh and S. S. Wil-
son, “Prostate Cancer Detection in Black and White Men
with Abnormal Digital Rectal Examination and Prostate
Specific Antigen Less than 4 ng/ml,” Journal of Urology,
Vol. 164, No. 6, 2000, pp. 1961-1963.
doi:10.1016/S0022-5347(05)66928-5
[10] W. J. Catalona, J. P. Richie, F. R. Ahmann, et al., “Com-
parison of Digital Rectal Examination and Serum Prostate
Specific Antigen in the Early Detection of Prostate Can-
cer: Results of a Multicenter Clinical Trial of 6630 Men,”
Journal of Urology, Vol. 151, No. 5, 1994, pp. 1283-1290.
[11] C. Gosselaar, M. J. Roobol, S. Roemeling, T. H. van der
Kwast and F. H. Schröder, “Screening for Prostate Can-
cer at Low PSA Range: The Impact of Digital Rectal
Examination on Tumor Incidence and Tumor Character-
istics,” The Prostate, Vol. 67, No. 2, 2007, pp. 154-161.
doi:10.1002/pros.20501
[12] F. H. Schröder, M. Roobol-Bouts, A. N. Vis, T. van der
Kwast and R. Kranse, “Prostate-Specific Antigen-Based
Early Detection of Prostate Cancer-Validation of Screen-
ing without Rectal Examination,” Urology, Vol. 57, No. 1,
2001, pp. 83-90.
[13] C. Gosselaar, M. J. Roobol, R. van den Bergh, T. Wolters
and F. H. Schroder, “Digital Rectal Examination and the
Diagnosis of Prostate Cancer—A Study Based on 8 Years
and Three Screenings within the European Randomized
Study of Screening for Prostate Cancer (ERSPC), Rot-
terdam,” European Urology, Vol. 55, No. 1, 2009, pp.
139-147. doi:10.1016/j.eururo.2008.03.079
[14] P. M. Beemsterboer, R. Kranse, H. J. de Koning, J. D.
Habbema and F. H. Schroder, “Changing Role of 3 Screen-
ing Modalities in the European Randomized Study of
Screening for Prostate Cancer (Rotterdam),” International
Journal of Cancer, Vol. 84, No. 4, 1999, pp. 437-441.
doi:10.1002/(SICI)1097-0215(19990820)84:4<437::AID-
IJC19>3.0.CO;2-S
[15] O. T. Okotie, A. K. Roehl, M. Han, S. Loeb, S. N. Gashti
and W. J. Catalona, “Characteristics of Prostate Cancer
Detected by Digital Rectal Examination Only,” Urology,
Vol. 70, No. 6, 2007, pp. 1117-1120.
doi:10.1016/j.urology.2007.07.019
[16] C. Gosselaar, M. J. Roobol, S. Roemeling and F. H.
Schroder, “The Role of the Digital Rectal examination in
Subsequent Screening Visits in the European Random-
ized Study of Screening for Prostate Cancer (ERSPC),
Rotterdam,” European Urology, Vol. 54, No. 3, 2008, pp.
581-588. doi:10.1016/j.eururo.2008.03.104
[17] M. I. Thompson, D. K. Pauler, P. J. Goodman, et al.,
“Prevalance of prostate cancer among men with a pros-
tate-specific antigen level ≤ 4 ng per milliliter,” The New
England Journal of Medicine, Vol. 350, No. 22, 2004, pp.
2239-2246. doi:10.1056/NEJMoa031918
Copyright © 2011 SciRes. OJU